SCHEMBL30762995

SCHEMBL30762995

Cc1cccc(NC(=O)O)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.74
KMT2A Q03164 5/20 0.67
MEN1 O00255 4/20 0.67
RXFP1 Q9HBX9 1/20 0.67
ALDH1A1 P00352 2/20 0.64
KCNK3 O14649 2/20 0.61
KCNK9 Q9NPC2 2/20 0.61
KCNH2 Q12809 1/20 0.61
POLB P06746 1/20 0.61
PKM P14618 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HPGD P15428 1/20 0.61
CYP1A2 P05177 1/20 0.60
EGFR P00533 1/20 0.60
MMP1 P03956 1/20 0.60
MMP2 P08253 1/20 0.60
MMP9 P14780 1/20 0.60
MAOA P21397 1/20 0.60
MAOB P27338 1/20 0.60
GAA P10253 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692386 1.00 HSD17B10 (0.74) HSD17B10KMT2AMEN1RXFP1ALDH1A1
Hydrochloric Acid SCHEMBL9576706 0.98 HSD17B10 (0.71) HSD17B10KMT2AMEN1RXFP1ALDH1A1
SCHEMBL13681314 0.88 CNR1 (0.65) HSD17B10KMT2AMEN1RXFP1ALDH1A1
Isobutyramide SCHEMBL28001869 0.88 HSD17B10 (0.59) HSD17B10KMT2AMEN1RXFP1ALDH1A1
SCHEMBL23581565 0.88 HSD17B10 (0.59) HSD17B10KMT2AMEN1RXFP1ALDH1A1
SCHEMBL29703055 0.87 SMN1; SMN2 (0.77) HSD17B10KMT2AMEN1RXFP1ALDH1A1
SCHEMBL4416620 0.87 SMN1; SMN2 (0.77) HSD17B10KMT2AMEN1RXFP1ALDH1A1
SCHEMBL21567990 0.87 HSD17B10 (0.74) HSD17B10KMT2AMEN1RXFP1ALDH1A1
SCHEMBL11858223 0.86 GPR35 (0.67) HSD17B10KMT2AMEN1KCNK3KCNK9
SCHEMBL17400848 0.86 GPR35 (0.74) HSD17B10KMT2AMEN1RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568668-A2 GPR6 INVERSE AGONISTS MapLight Therapeutics, Inc. (US) 2025-06-18 EP disclosed
WO-2024036288-A2 GPR6 INVERSE AGONISTS MAPLIGHT THERAPEUTICS, INC. (US) 2024-02-15 WO disclosed